Rottlerin inhibits chlamydial intracellular growth and blocks chlamydial acquisition of sphingolipids from host cells

Applied and Environmental Microbiology

Volumn 74, Issue 4, 2008, Pages 1243-1249

  Shivshankar, Pooja ^a   Lei, Lei ^a   Wang, Jie ^a   Zhong, Guangming ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODIVERSITY; BIOSYNTHESIS; CELL CULTURE; GROWTH KINETICS; PROTEINS;

GOLGI APPARATUS; MINIMAL INHIBITION CONCENTRATION; SPHINGOLIPIDS;

ENZYME INHIBITION;

ROTTLERIN; SPHINGOLIPID;

ANTIMICROBIAL ACTIVITY; BACTERIUM; CELL ORGANELLE; GROWTH RESPONSE; INHIBITION; TOXIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CELL CULTURE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG MECHANISM; GOLGI COMPLEX; HOST CELL; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN SYNTHESIS;

ACETOPHENONES; BENZOPYRANS; CHLAMYDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HELA CELLS; HUMANS; SPECIES SPECIFICITY; SPHINGOLIPIDS;

CHLAMYDIA; MAMMALIA;

EID: 39649091205     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.02151-07     Document Type: Article

References (33)

1. Ashkar, A. A., X. D. Yao, N. Gill, D. Sajic, A. J. Patrick, and K. L. Rosenthal. 2004. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190:1841-1849.
2. Balakrishnan, A., B. Patel, S. A. Sieber, D. Chen, N. Pachikara, G. Zhong, B. F. Cravatt, and H. Fan. 2006. Metalloprotease inhibitors GM6001 and TAPI-0 inhibit the obligate intracellular human pathogen Chlamydia trachomatis by targeting peptide deformylase of the bacterium. J. Biol. Chem. 281:16691-16699.
3. Beatty, W. L. 2006. Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis. J. Cell Sci. 119:350-359.
4. Campbell, L. A., and C. C. Kuo. 2004. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2:23-32.
5. Carabeo, R. A., D. J. Mead, and T. Hackstadt. 2003. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc. Natl. Acad. Sci. USA 100:6771-6776.
6. Choi, E. Y., S. Lee, H. M. Oh, Y. D. Kim, E. J. Choi, S. H. Kim, S. W. Kim, S. C. Choi, and C. D. Jun. 2007. Involvement of protein kinase Cδ in iron chelator-induced IL-8 production in human intestinal epithelial cells. Life Sci. 80:436-445.
7. Clark, A. S., K. A. West, P. M. Blumberg, and P. A. Dennis. 2003. Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCδ promotes cellular survival and chemotherapeutic resistance. Cancer Res. 63:780-786.
8. Cong, Y., M. Jupelli, M. N. Guentzel, G. Zhong, A. K. Murthy, and B. P. Arulanandam. 2007. Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection. Vaccine 25:3773-3780.
9. Deka, S., J. Vanover, S. Dessus-Babus, J. Whittimore, M. K. Howett, P. B. Wyrick, and R. V. Schoborg. 2006. Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells. Cell. Microbiol. 8:149-162.
10. De Witt, B. J., A. D. Kaye, I. N. Ibrahim, T. J. Bivalacqua, F. M. D'Souza, R. E. Banister, A. S. Arif, and B. D. Nossaman. 2001. Effects of PKC isozyme inhibitors on constrictor responses in the feline pulmonary vascular bed. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L50-L57.
11. Greene, W., Y. Xiao, Y. Huang, G. McClarty, and G. Zhong. 2004. Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect. Immun. 72:451-460.
12. Gupta, G. D. 2004. Ceramide trafficking: learning from the rebels. J. Biosci. 29:209-210.
13. Hackstadt, T., E. R. Fischer, M. A. Scidmore, D. D. Rockey, and R. A. Heinzen. 1997. Origins and functions of the chlamydial inclusion. Trends Microbiol. 5:288-293.
14. Hackstadt, T., D. D. Rockey, R. A. Heinzen, and M. A. Scidmore. 1996. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J. 15:964-977.
15. Hackstadt, T., M. A. Scidmore, and D. D. Rockey. 1995. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc. Natl. Acad. Sci. USA 92: 4877-4881.
16. Hu, H., G. N. Pierce, and G. Zhong. 1999. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Investig. 103:747-753.
17. Kuriyama, M., T. Taniguchi, Y. Shirai, A. Sasaki, A. Yoshimura, and N. Saito. 2004. Activation and translocation of PKCδ is necessary for VEGF-induced ERK activation through KDR in HEK293T cells. Biochem. Biophys. Res. Commun. 325:843-851.
18. Luo, J., G. Liu, Y. Zhong, T. Jia, K. Liu, D. Chen, and G. Zhong. 2007. Characterization of hypothetical proteins Cpn0146, 0147, 0284 and 0285 that are predicted to be in the Chlamydia pneumoniae inclusion membrane. BMC Microbiol. 7:38.
19. + CTL. J. Immunol. 178:7814-7821.
20. Matassa, A. A., L. Carpenter, T. J. Biden, M. J. Humphries, and M. E. Reyland. 2001. PKCδ is required for mitochondrial-dependent apoptosis in salivary epithelial cells. J. Biol. Chem. 276:29719-29728.
21. Scidmore, M. A., E. R. Fischer, and T. Hackstadt. 2003. Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Infect. Immun. 71:973-984.
22. Sherman, K. J., J. R. Daling, A. Stergachis, N. S. Weiss, H. M. Foy, S. P. Wang, and J. T. Grayston. 1990. Sexually transmitted diseases and tubal pregnancy. Sex. Transm. Dis. 17:115-121.
23. Soltoff, S. P. 2007. Rottlerin: an inappropriate and ineffective inhibitor of PKCδ. Trends Pharmacol. Sci. 28:453-458.
24. Stephens, R. S., S. Kalman, C. Lammel, J. Fan, R. Marathe, L. Aravind, W. Mitchell, L. Olinger, R. L. Tatusov, Q. Zhao, E. V. Koonin, and R. W. Davis. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754-759.
25. Su, H., G. McClarty, F. Dong, G. M. Hatch, Z. K. Pan, and G. Zhong. 2004. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 279:9409-9416.
26. Tillman, D. M., K. Izeradjene, K. S. Szucs, L. Douglas, and J. A. Houghton. 2003. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res. 63:5118-5125.
27. Tse, S. M., D. Mason, R. J. Botelho, B. Chiu, M. Reyland, K. Hanada, R. D. Inman, and S. Grinstein. 2005. Accumulation of diacylglycerol in the Chlamydia inclusion vacuole: possible role in the inhibition of host cell apoptosis. J. Biol. Chem. 280:25210-25215.
28. Uchida, T., N. Iwashita, M. Ohara-Imaizumi, T. Ogihara, S. Nagai, J. B. Choi, Y. Tamura, N. Tada, R. Kawamori, K. I. Nakayama, S. Nagamatsu, and H. Watada. 2007. Protein kinase Cδ plays a non-redundant role in insulin secretion in pancreatic beta cells. J. Biol. Chem. 282:2707-2716.
29. van Tiel, C. M., J. Westerman, M. A. Paasman, M. M. Hoebens, K. W. Wirtz, and G. T. Snoek. 2002. The Golgi localization of phosphatidylinositol transfer protein beta requires the protein kinase C-dependent phosphorylation of serine 262 and is essential for maintaining plasma membrane sphingomyelin levels. J. Biol. Chem. 277:22447-22452.
30. Wolf, K., H. J. Betts, B. Chellas-Gery, S. Hower, C. N. Linton, and K. A. Fields. 2006. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61:1543-1555.
31. Zeeh, J. C., M. Zeghouf, C. Grauffel, B. Guibert, E. Martin, A. Dejaegere, and J. Cherfils. 2006. Dual specificity of the interfacial inhibitor brefeldin A for arf proteins and sec7 domains. J. Biol. Chem. 281:11805-11814.
32. Zhang, D., V. Anantharam, A. Kanthasamy, and A. G. Kanthasamy. 2007. Neuroprotective effect of protein kinase Cδ inhibitor rottlerin in cell culture and animal models of Parkinson's disease. J. Pharmacol. Exp. Ther. 322: 913-922.
33. Zhao, H., W. Tian, and D. M. Cohen. 2002. Rottlerin inhibits tonicity-dependent expression and action of TonEBP in a PKCδ-independent fashion. Am. J. Physiol. Renal Physiol. 282:F710-F717.